文献速递生殖医学

JUNO——精子IZUMO1的受体——在人卵母细胞表达且为人受精所必需

JUNO, the receptor of sperm IZUMO1, is expressed by the human oocyte and is essential for human fertilisation.
PubMed 文献 · Hum Reprod · 2019-01-01

本研究制备抗人JUNO单克隆抗体,用免疫染色和体外受精实验检测人卵母细胞JUNO的表达及其在受精中的作用;发现JUNO表达于人卵母细胞质膜且随卵母细胞成熟逐渐表达,抗hJUNO单抗完全阻断人精子与去透明带卵母细胞的融合。

要点

  • JUNO蛋白表达于人卵母细胞质膜,且随卵母细胞成熟逐渐表达。
  • 抗hJUNO单克隆抗体(FJ2E4、FJ8E8、FJ4F5)可识别可溶性重组人JUNO蛋白及约25 kDa蛋白。
  • 去透明带人卵母细胞在抗hJUNO单抗存在下授精后未被人类精子受精。

核心结论

  • JUNO蛋白存在于人卵母细胞质膜,其被单克隆抗体抑制后完全阻断配子融合,提示JUNO参与人受精过程中配子膜融合。

研究设计与样本

  • 用转染推定人JUNO序列的HEK细胞(HEK-hJUNO)免疫小鼠制备抗人JUNO单克隆抗体。
  • 抗体用于免疫染色实验及与 human gametes(GERMETHEQUE Biobank)进行的体外受精实验。

主要发现

  • 三株纯化单克隆抗体FJ2E4(IgG1)、FJ8E8(IgG1)、FJ4F5(IgG2a)识别可溶性重组人JUNO蛋白及HEK-hJUNO提取物中预期分子量25 kDa的蛋白。
  • 可溶性重组人IZUMO蛋白抑制抗hJUNO单抗与表达hJUNO细胞的结合。
  • 免疫染色显示JUNO蛋白存在于人卵母细胞质膜,且随卵母细胞成熟逐渐表达。
  • 去透明带人卵母细胞在抗hJUNO单抗存在下授精后未被人类精子受精。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 根据法国生物伦理法律,功能实验使用去透明带卵母细胞,这当然不能完全涵盖所有正常体内生理条件。
  • 这些体外实验确实提供了关于精子-卵母细胞膜相互作用的直接信息。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Is JUNO protein present at the surface membrane of human oocytes and involved in the fertilisation process? SUMMARY ANSWER: JUNO protein is expressed on the plasma membrane of human oocytes and its inhibition by a monoclonal antibody completely blocks gamete fusion. WHAT IS KNOWN ALREADY: Fusion of gamete membranes is the culminating event of the fertilisation process, but its molecular mechanisms are poorly understood. Until now, three molecules have been shown to be essential: CD9 tetraspanin in the oocyte, Izumo1 protein on the sperm and Juno, its corresponding receptor on the oocyte. Oocyte CD9 and sperm IZUMO1 have been identified in human gametes and their interaction is also well-conserved among several mammalian species. The presence of JUNO on human oocytes, however, has not yet been reported, nor has its role in fertilisation been investigated. STUDY DESIGN, SIZE, DURATION: We selected an anti-human JUNO antibody in order to investigate the presence of JUNO on the oocyte membrane surface and studied its potential involvement in gamete membrane interaction during fertilisation. PARTICIPANTS/MATERIALS, SETTING, METHODS: Monoclonal antibodies against human JUNO (anti-hJUNO mAb) were produced by immunisation of mice with HEK cells transfected with the putative human JUNO sequence (HEK-hJUNO). These antibodies were used for immunostaining experiments and in vitro fertilisation assays with human gametes (GERMETHEQUE Biobank). MAIN RESULTS AND THE ROLE OF CHANCE: Three hybridoma supernatants, verified by immunostaining, revealed specifically HEK-hJUNO cells. The three purified monoclonal antibodies, FJ2E4 (IgG1), FJ8E8 (IgG1) and FJ4F5 (IgG2a), recognised the soluble recombinant human JUNO protein and, in a western blot of HEK-hJUNO extracts, a protein with an expected MW of 25 kDa. In addition, soluble recombinant human IZUMO protein inhibited the binding of anti-hJUNO mAbs to cells expressing hJUNO. Using these anti-hJUNO mAbs in immunostaining, we identified the presence of JUNO protein at the plasma membrane of human oocytes. Furthermore, we revealed a progressive expression of JUNO according to oocyte maturity. Finally, we showed that human zona-free oocytes, inseminated in the presence of anti-hJUNO mAb, were not fertilised by human sperm. These results suggest that, as seen in the mouse, JUNO is indeed involved in human gamete membrane fusion during fertilisation. LARGE-SCALE DATA: N/A. LIMITATIONS, REASONS FOR CAUTION: In accordance with French bioethics laws, functional tests were performed using zona-free oocytes, which of course does not fully encompass all normal in vivo physiological conditions. However, these in vitro tests do provide direct information regarding sperm-oocyte membrane interactions. WIDER IMPLICATIONS OF THE FINDINGS: Mechanisms of gamete fusion appear to be homologous between mice and humans. However, some differences do exist and analysing the human mechanisms is essential. In fact, this is the first report describing the presence of JUNO on human oocytes and its involvement in human fertilisation. This discovery allows further examination of the understanding of molecular mechanisms that drive gamete fusion: a crucial challenge at a time when infertility affects 16% of reproductively active couples. STUDY FUNDING/COMPETING INTERESTS: This work was supported by the Agence Nationale pour la Recherche, Grant no. ANR-13-BVS5-0004, and by Association Institut du Cancer et d'Immunogénétique (ICIG). There are no competing interests.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Jean C, Haghighirad F, Zhu Y, et al. JUNO, the receptor of sperm IZUMO1, is expressed by the human oocyte and is essential for human fertilisation. Hum Reprod. 2019. PMID: 30517645. doi:10.1093/humrep/dey340

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。